Intriguingly, AZD2461 targets only proliferating cells with DSB repair dysfunction (i.e. BRCA- and PTEN-deficient or low expressed genetic backgrounds), supporting the mechanism regarding the conversion of SSBs into DSBs during DNA replication that eventually leads to cell death in tumor cells with defective HR repair. This evidence concerns the gene PTEN and neoplasm.